Fillmed NCTF 135HA CE (5 × 3 mL)

Description

Fillmed NCTF 135HA is a CE-marked, injectable biorevitalising medical device designed for skin quality enhancement. It combines 5 mg/mL non crosslinked sodium hyaluronate with a rich “polyrevitalising” formula containing vitamins, amino acids, nucleic acids, minerals, and co-enzymes. This cocktail supports fibroblast activity, promoting collagen and elastin synthesis, hydration, and dermal renewal. The mechanism of action is not volumetric filling, but biological stimulation of the dermis, helping to improve skin radiance, elasticity, and density.

What It’s Similar To

In terms of function and category, NCTF 135HA can be compared to other skin boosters such as Sunekos® or Profhilo®. Like Sunekos, it uses a multi-component formula (not just hyaluronic acid) to stimulate skin renewal; unlike cross-linked volumising fillers, it doesn’t add structure or volume, similar to Profhilo, but its action is more focused on skin revitalisation rather than deep hydration or bi-restructuring. The key difference lies in the ingredient profile: NCTF includes a broad mix of vitamins, amino acids, nucleic acids, minerals and co-enzymes alongside HA, giving it a richer “biological” stimulation.
This comparison is provided for clinical orientation only and does not imply interchangeability.

Treatment Areas / Indications

According to the manufacturer and distributor information, NCTF 135HA is indicated for:

• Face (including periorbital area)

• Neck

• Décolleté

• Hands

• Arms (some sources mention inner arms)

Usage / Administration (IFU-Only)

• Injection depth: Superficial dermis (intradermal).

• Needle gauge: According to clinical use, 32 G × 4 mm classic needle has been used.

• Frequency / number of sessions: The standard recommended protocol is 3 sessions spaced 15 days apart, followed by 2 sessions spaced one month apart.

• Volume per injection / point: The IFU does not publicly specify a fixed “volume per point / papule” for each injection site. (The public IFU / SSCP does not provide a detailed per-point dosage.)

• Professional-use disclaimer: Administered only by qualified medical professionals, under aseptic conditions.

Ingredient List

• Non–crosslinked sodium hyaluronate (5 mg/mL)

• 12 vitamins (A, B-complex including B1, B2, B3, B5, B6, B8, B9, B12; C; E)

• 24 amino acids (e.g., glycine, proline, leucine, etc.)

• 5 nucleic acids (deoxyadenosine, deoxycytidine, etc.)

• 6 minerals (e.g., calcium, potassium, magnesium)

• 6 co-enzymes (e.g., NAD, FAD, CoA)

• Other excipients: glutathione, polysorbate 80, glucuronic acid / lactone, glucosamine, dextrose (anhydrous)

Presentation & Longevity

• Packaging: 5 × 3 mL sterile vials.

• Shelf life: Not publicly specified in the manufacturer SSCP.

• Treatment duration / longevity: According to clinical evidence, skin improvements (wrinkles, radiance, density) were still measurable at 120 days (4 months) after the third injection in studies. Maintenance protocols typically follow every 3–6 months as used in practice.

• Safety Notes / Contraindications

From publicly available prescribing and distributor information:

1. Hypersensitivity: Contraindicated in patients with known allergy or hypersensitivity to any component (e.g., hyaluronic acid).

2. Active infection: Avoid in areas with active skin infection, inflammation, or wounds.

3. Autoimmune or clotting disorders: Use cautiously (or avoid) in patients with autoimmune disease, bleeding/clotting disorders.

4. Pregnancy / Breastfeeding: Not recommended during pregnancy or in breastfeeding mothers (precaution due to lack of safety data).

Regulatory Status

• CE-marked (European Conformity) medical device.

• Regulatory classification: injectable medical device for professional use (as stated by Fillmed).

FAQ

Q1: How does NCTF 135HA actually improve skin quality?
A: NCTF 135HA works by delivering a synergistic blend of non-crosslinked hyaluronic acid and vital “polyrevitalising” nutrients (vitamins, amino acids, nucleic acids, minerals, co-enzymes) into the dermis. This stimulates fibroblasts, which in turn produce more collagen and elastin, improving elasticity, hydration, and skin tone over time.

Q2: Is NCTF 135HA safe for use, and what side-effects are common?
A: Clinical evidence and safety performance reports show that most adverse reactions are mild: bruising (~36%) and redness (~23%) are common but generally light in intensity, with nearly half resolving within 48 hours. It should not be used in patients with hypersensitivity, active infection, or certain systemic conditions.

Q3: How often should treatments be performed?
A: According to Fillmed’s recommended protocol, you would typically administer 3 sessions spaced 15 days apart, followed by 2 further sessions with one-month intervals.Some practitioners then use maintenance treatments every 3–6 months.

Q4: How long do the effects last?
A: In clinical studies, improvements in skin density, radiance, and the appearance of fine lines were still measurable at 120 days after the treatment course. Maintenance treatments can help sustain results.

Q5: How does NCTF 135HA compare with other skin boosters like Profhilo or Sunekos?
A: Unlike volumising fillers, NCTF 135HA doesn’t add structure—its strength lies in “biological revitalisation.” Compared to Sunekos, which also uses amino acids, NCTF provides a more complex mix, including nucleic acids and co-enzymes. Compared to Profhilo, which focuses on very high-purity hyaluronic acid and bi-restructuring, NCTF is more nutrient-rich and stimulatory. This comparison is for clinical orientation and does not imply interchangeability.